Posted inBlog
Pratap Premchand Agarwal vs Jawala Real Estate: Legal Dispute and Refund Claims
Explore the legal complaint filed by Pratap Premchand Agarwal against Jawala Real Estate seeking substantial refunds, interest, and compensation.
Posted inBlog
Builder-Buyer Dispute: Legal Case Over Housing Project Delays and Refunds
Learn about a builder-buyer dispute regarding housing project delays, unfair agreements, and demands for a full refund of booking amounts.
Posted inBlog
Understanding Corporate Insolvency Appeals Over Resolution Plan Approvals
Explore recent legal appeals concerning corporate insolvency resolution plan approvals and tribunal decisions in India.
Posted inBlog
CAAR Mumbai Rules on Separate Custom Duty Classification for Siemens IPC Components
Discover the latest CAAR Mumbai ruling regarding the separate custom duty classification for Siemens IPC motherboards, chassis, and power supplies.
Posted inBlog
Polycab India Receives NCLAT Stay on NCLT Insolvency Order
The NCLAT has granted a stay on the NCLT insolvency order against Polycab India. Read about the National Stock Exchange filing and shareholder impact.
Posted inBlog
ITAT Surat Orders Fresh Verification of 2.99 Crore Agricultural Land Capital Gains
ITAT Surat mandates a fresh assessment of 2.99 crore capital gains, agricultural land status, local population criteria, and Section 54B tax exemptions.
Posted inBlog
Best VPN Providers for Privacy, Security, and Speed in 2026
Discover top VPN providers evaluated on encryption, privacy, speed, server coverage, and device connections to protect your digital footprint.
Posted inBlog
Understanding GST on Education: Exemptions and Legal Complexities
Explore the boundaries of GST exemptions for educational institutions, coaching centers, affiliation fees, and emerging legal issues in the sector.
Posted inBlog
ITAT Kolkata Quashes Assessment Over ACIT Pecuniary Jurisdiction
ITAT Kolkata sets aside a major Section 68 assessment worth Rs.13.29 crore, ruling that the ACIT lacked proper pecuniary jurisdiction.
Posted inBlog
Zydus and Formycon Keytruda Biosimilar Accepted for USFDA Review
The USFDA has accepted the Biologics License Application for Zydus and Formycon's Keytruda biosimilar, marking a major milestone for shareholders.